EUROPE S LEADING INVESTMENT AND BIOPARTNERING CONFERENCE

EUROPE’S LEADING INVESTMENT AND BIOPARTNERING CONFERENCE WHERE GREAT MINDS, SMART MONEY AND KEY DEALMAKERS MEET PROGRAMME OF EVENTS LONDON APRIL25-2...
12 downloads 1 Views 1MB Size
EUROPE’S LEADING INVESTMENT AND BIOPARTNERING CONFERENCE

WHERE GREAT MINDS, SMART MONEY AND KEY DEALMAKERS MEET

PROGRAMME OF EVENTS LONDON APRIL25-272016 NOVOTEL LONDON WEST, UK

+ 160+ 1000 DELEGATES DELEGATES

LIFE SCIENCE INVESTMENT

ORGANISED BY

EMERGING

2500+

PRESENTATIONS

MEETINGS

100+

R&D COMPANY

ONE-TO-ONE PARTNERING

Partnering provided by www.biotrinity.com @biotrinity #BioTrinity2016

www.biotrinity.com • www.biotrinity.com • www.biotrinity.com •

YOU’VE GOT TO SEE IT TO BELIEVE IT Now Europe’s leading investment and biopartnering conference, BioTrinity is the event that brings together 1000+ European R&D organisations, senior executives from global pharma corporations and active investor companies across the life sciences industry to do business. Built over 10 years, here’s 10 reasons why you need be at the best BioTrinity yet:  Proven business generation – BioTrinity has become

the ‘must attend’ event for executives to secure investment, financing, partnerships and business  One-to-one partnering meetings at BioTrinity are

catalysts – meet and secure business partners of the future during meetings over two and a half days through  Pick from over 100 of Europe’s best life sciences R&D

 Impressive line-up of life science

and investment experts keen to share industry insight on trends, innovations, securing investment and deal-making strategies  Save £50 off the standard rate

by booking your ticket now – you won’t be disappointed  Discover new products and

company showcases  BioTrinity offers intensive opportunities to be seen

services from 60 exciting exhibitors

and heard by the perfect investors, pharma’s hottest  Cost effective and efficient route dealmakers and partners - 100+ active VC and corporate to grow your network with new venture firms are expected contacts easily accessible at the social events  2016 brings more benefits than ever for R&D company showcase presenters – opportunities for private follow-  Dedicated MediTrinity stream for up meetings, invitations to the first VIP Investor and those with a passion or interest CEO Networking lunch plus a chance to enter the of medtech focused panels, Perfect Pitch session showcases and workshops

BOOK TODAY FOR THE BEST PRICES £749

£949

£500

OBN MEMBERS

NON MEMBERS

ACADEMIC RATE

+VAT

+VAT

+VAT

Prices (excluding the academic rate) will increase after 31 March 2016. Visit www.biotrinity.com for prices for presenting a company showcase or for exhibition space.

GO TO WWW.OBN.ORG.UK TO FIND OUT MORE ABOUT BECOMING AN OBN MEMBER

1

• www.biotrinity.com • www.biotrinity.com • www.biotrinity.com

2500+

PARTNERING

Book one-to-one meetings in private booths with your choice of over 1000 delegates

+ 1000 DELEGATES WORKSHOPS

Attend interactive workshops on the latest industry trends and advice at no additional cost

PANELS

Meet and extend your network at The BioTrinity Welcome Reception, Connect for Drinks Reception and the Big London Networking Party

MEETINGS

SHOWCASES

Your choice to view presentations from some of the best emerging European biotech and medtech companies

100+

EMERGING

R&D COMPANY

PRESENTATIONS

Top global pharma execs, investors and CEOs form the hot topic panels delivering the ‘Vision for Life Sciences 2030’

NETWORKING

ONE-TO-ONE PARTNERING

EXHIBITION

Discover the latest products and services through the high traffic exhibition hall incorporating informal networking hubs

160+

LIFE SCIENCE INVESTMENT

DELEGATES

VISIT WWW.BIOTRINITY.COM TO BOOK YOUR TICKET TO PARTICIPATE

www.biotrinity.com • www.biotrinity.com • www.biotrinity.com • www.biotrinity.com • www.biotrinity.com • www.biotrinity.com

THE BIOTRINITY 2016 PROGRAMME

Vision for Life Sciences 2030 Packed with events and continually evolving, here’s a snapshot of opportunities.

Monday 25 April 18:30 - 20:30 One-to-One Partnering Open, Delegate & Speaker Registration and the BioTrinity 2016 Welcome Reception Tuesday 26 April 07:30

Delegate/Spreaker Registration and Exhibition Hall Open

08:00 - 18:30 One-to-One Partnering Open 09:00 - 09:05 BioTrinity and MediTrinity Welcome and Opening Remarks; John Harris, CEO, OBN 09:05 - 09:15 Keynote Talk: “A Manifesto for Health and Life Sciences in the UK” George Freeman, Minister for Life Sciences 09:15 - 09:30 Keynote Talk: “Fast Forward: Vision for Biotech 2030” Jim Mellon, Serial Entrepreneur and Founder of Mann Bioinvest BioTrinty 09:30-10:10 Panel Discussion Building Long-Term Value Without an Exit in Mind Chaired by: Tim Haines, Abingworth Saku Saha, Woodford Investment Management Nigel Pitchford, Imperial Innovations Tim Bird, Fieldfisher Miguel Stevens, UCB Biopharma sprl Ed Hodgkin, Syncona Partners Kevin Bottomley, Results Healthcare

09:40 - 10:20 Panel Discussion What are the Trends in Innovative Medtech Investment Every CEO Should Know? Chaired by: Alan O’Connell, Seroba Life Sciences Rainer Strohmenger, Wellington Partners Bruno Montanari, Omnes Capital Dani Bach, Imperial Innovations Ena Prosser, Fountain Healthcare Partners

10:10-10:50 Panel Discussion How Will Immuno-oncology Deliver on its Promise? Chaired by: John Carroll, FierceBiotech Hyam Levitsky, Juno Therapeutics Carl Decicco, Bristol-Myers Squibb Mene Pangalos, AstraZeneca Iain Dukes, MSD Luc Dochez, Tusk Therapeutics

10:20 - 11:00 Panel Discussion Precision Medicine: How to Collaborate on Big Data to Generate Value in Drug Development Chaired by: Alison Dennis, Fieldfisher John McKinley, Precision Medicine Catapult Mark Beggs, Stratified Medicines Scotland Tero Silvola, BC Platforms Mark Caulfield, Genomics England Nick La Thangue, Oxford Cancer Biomarkers

11:10 - 11:30 EY Beyond Borders Report

EY Beyond Borders Report - Medtech

11:30 - 12:30 Company Showcases - Biotech Later Stage Virttu Biologics, BerGenBio, Sanofi, Neovacs, Wickham Laboratories

Company Showcases - Medtech Later Stage Tissue Regenix, Acarix A/S, OBS Medical

11:30 - 13:30 UK Innovation Poster Presentations - Sponsored by Oxford Academic Health Science Network 12:30 - 14:00 Lunch, Networking and Exhibition NEW! VIP CEO and Investor Networking Lunch, Sponsored by SyndicateRoom 13:30 - 14:10 Panel Discussion Can European Capital Take Biotechs All the Way? Chaired by: Antoine Papiernik, Sofinnova Partners Claire Terlouw, Numis Securities - tbc Rajeev Shah, RA Capital - tbc Sander van Deventer, Forbion Capital - tbc Anne Marden, JP Morgan Asset Management - tbc

Panel Discussion How Patient Groups Believe Technology Will Impact Their Experience by 2030 Chaired by: Tina Tan, Clinica Medtech Intelligence Keith Errey, Isansys Lifecare Sophie Barratte, Cellnovo Michael Seres, Patient and Founder, 11Health Ralph Holme, Action on Hearing Loss Arthur Roach, Parkinson’s UK Matthew Goodman, Mapmyhealth

14:10 - 17:30 Company Showcases - Biotech Therapeutics Sponsored and chaired by Results Healthcare, Karus Therapeutics, CN Bio Innovations, APIM Therapeutics, PIQUR Therapeutics, Peptinnovate, Sareum, ImevaX, APEPTICO, Tusk Therapeutics, PCI Biotech, Cellestia Biotech, Akinion Pharmaceuticals, Amal Therapeutics, Oryzon Genomics

Company Showcases - Meditrinity Safeguard Biosystems BeamLine Diagnostics NIMGenetics

Company Showcases - Biotech Therapeutics Nanobiotix, Synpromics, Blueberry Therapeutics, OncoCor, Nanomerics, Abzena, Somanautix Company Showcases - Biotech Advanced Therapies Ryboquin, Alfacyte, MiNA Therapeutics, acpeth, Asterias Therapeutics 14:35 - 15:25 Workshop: Open innovation and the translation of university research into new companies Hosted by Oxford Academic Health Science Network Workshop: Patients Before Protocols, Patient Centric Clinical Trials Hosted by World Courier

15:35 - 16:25 Workshop: Introducing Engineering Biology: Creating High Value Products & Processes Hosted by SynbiCITE Workshop: The other side of the innovation ledger: changes in early-stage sourcing and deal-making Hosted by The Association of the British Pharmaceutical Industry 16:35 - 17:25 Workshop: Genome editing technology - the ethical viewpoint Hosted by Fieldfisher 17:30 - 18:30 Connect for Drinks Reception, co-sponsored by Milton Park 18:30 - 20:30 The Big London Networking Party, co-sponsored by Bristol-Myers Squibb Wednesday 27 April Delegate/Spreaker Registration and Exhibition Hall Open

08:00 - 16:30

One-to-One Partnering

09:00 - 09:20

Keynote: ‘Inspiring Innovation’ Stephen Caddick, Director of Innovation, The Wellcome Trust

09:20 - 09:30

Keynote: ‘Dementia Discovery Fund: A New Collaborative Approach to Major Unmet Medical Needs’ Tetsuyuki Maruyama, CSO, Dementia Discovery Fund

09:30 - 10:10

Panel Discussion Is the UK Becoming the European Powerhouse for Biotech? Chaired by: Andrew Ward, Financial Times John Jeans, Advisor to the UK Prime Minister Chris Doherty, Manchester Science Partnerships Zahid Latif, Innovate UK Virginia Acha, The Association of the British Pharmaceutical Industry Henk Joos, Flanders Bio

10:10 - 10:50

Panel Discussion Crystalizing Value Without The Equity Markets Chaired by: Stephanie Léouzon, Torreya Partners Genghis Lloyd-Harris, Abingworth Ray Barlow, Amgen Margarita Chavez, AbbVie Daniel Mahoney, Polar Capital Graziano Seghezzi, Soffinova Partners

10:50 - 10:10

Refreshments, Networking, Exhibition

11:10 - 11:50

Panel Discussion Debate: Is the Biotech Boom Sustainable? Co-Chair: Mike Ward, SCRIP Intelligence Co-Chair: Sam Fazeli, Bloomberg Intelligence Kevin Johnson, Medicxi Ventures Kate Bingham, SV Life Sciences Terence Porter, Takeda Pharmaceuticals Debbie Harland, SR One David U’Prichard, BioMotiv Reza Halse, MRL Ventures - tbc

11:50 - 12:30

Panel Discussion Europe’s most notable transactions: deal-making insight from the trenches Co-chair: Fintan Walton, CEO, PharmaVentures Co-chair: Lubor Gaal, Almirall - tbc Malcolm Weir, Heptares Frank Grams, Sanofi Gilles Nobecourt, Edmond de Rothschild Investment Partners Edward van Wezel, Biogeneration Ventures Jenny Laird, Eli Lilly & Company - tbc Judith Hills, Ipsen Biopharm - tbc

12:30 - 13:30

Lunch, Networking and Exhibition

13:30 - 15:40

Company Showcase - Therapeutics Company Showcase - Platform Technologies

13:35 - 14:25

Workshop: Incentives for R&D companies to relocate to the UK Hosted by: UKTI

14:35 - 15:25

Workshop - Some slots still available. Contact us today for details.

Perfect Pitch Winner Announcement and Closing Remarks

15:50 - 16:30

Closing Drinks Reception and Conference Close

Correct at time of print 18/2/16

INVESTORS

Abingworth (UK) AbbVie (USA) Angel Capital Group Angels (Various) BioGeneration Ventures (The Netherlands) BioMotiv, LLC (United States) Cambridge Enterprise Seed Funds Cambridge Innovation Capital plc Capricorn Venture Partners (Belgium) Dementia Discovery Fund Duke Street Dynasty Bio/The Dynasty Fund Edmond de Rothschild Investment Partners (France) Epidarex Capital Finance Wales Fountain Healthcare Partners (Ireland) Gilde Healthcare (Netherlands) HBM Partners (Switzerland) Imperial Innovations Inventages IP Group JB Equity Joint Polish Investment Fund (Poland) Mann Bioinvest Limited MedCity Angels Medixci Ventures MedInnovate Mercia Fund Management MS Ventures (Netherlands) MVM Life Science Partners LLP NBGI Private Equity Limited NeoMed (Switzerland) New Wave Ventures Norgine Ventures Novo A/S (Denmark) O2h Ventures Limited Omnes Capital (France) Oxford Technology Pierre Fabre Fund for Innovation (France) Polar Capital Private Investors SEP Seroba Life Sciences (Ireland) SEVENTURE PARTNERS (France) Silicon Valley Bank Sofinnova Partners (France) SPARK Impact SR One SV Life Sciences Syncona Partners SyndicateRoom Takeda Ventures, Inc. (United States) Torreya Partners UCL Business PLC Ventac Partners (Spain) Visium Asset Management Wellington Partners (Germany) Woodford Investment Management Wren Capital Yorkville Advisors Global (United States) Ysios Capital (Spain)

GLOBAL PHARMA

07:30

15:40 - 15:50

BIOTRINITY 2016

MediTrinity

10:50 - 11:10 Refreshments, Networking, Exhibition

14:35-15:25

LOOK WHO HAS RECOGNISED THE VALUE OF BEING AT

AbbVie (USA and Europe) Amgen - (United Kingdom) AstraZeneca Bristol-Myers Squibb (USA) BTG International Inc (USA) Eli Lilly and Company Ipsen Biopharm (France) MSD (USA) PIERRE FABRE MEDICAMENT (France) Sanofi (United States) Takeda Pharmaceuticals (United States) Teva Pharmaceutical Industries (Netherlands) UCB Biopharma sprl (Belgium)

PARTICIPANTS

11:30 - 13:30 UK Innovation Poster Presentations Sponsored by Oxford Academic Health Science Network

13:30 - 15:00 NEW! Perfect Pitch A lively, fast-paced, interactive and entertaining session which sees ten young R&D companies pitching in front of a panel of investors, with the sole aim of being voted Perfect Pitch Champions 2016. The investor panel includes: Maina Bhaman, Imperial Innovations Graeme Martin, Takeda Ventures David Phillips, SR One Naveed Siddiqi, Edmond de Rothschild Investment Partners Andy Smith, MannBio - tbc Detlev Mennerich, Boehringer Ingelheim Venture Fund - tbc

11 Health and Technologies Ltd 2BIND GMBH (Germany) ABF Pharmaceutical Services (Austria) Abgentis Ltd ABPI Abzena plc Acarix A/S (Denmark) Accentus Medical Ltd Advantage Austria Air Liquide Air Products AJ Gallagher Akinion Pharmaceutical AB (Sweden) Albany Molecular Research Inc Albion Ventures LLP Alderley Park Alfacyte Ltd Almac Amal Therapeutics (Switzerland) AMRC apceth GmbH & Co. KG (Germany)

APEPTICO (Austria) APIM Therapeutics (Norway) Aptuit Asterias Biotherapeutics (United States) Aston University - Business Partnership Unit Atopix Therapeutics Ltd Autonomous University of Barcelona (Spain) BC Platforms (Switzerland) BeamLine Diagnostics BerGenBio (Norway) Bionow Bioshai (Israel) Biotechgate Black Swan Analysis Bloomberg Intelligence (UK) British Heart Foundation Brown Rudnick LLP Cambridge Healthcare & Biotech Cellestia Biotech (Switzerland) Cellnovo Group SA (France) Cello Health Consulting Citigate Dewe Rogerson Cleveland Patents and Trade Marks Clinica Medtech Intelligence Clinical Network Services (UK) Ltd Cobra Biologics Confluence Tax LLP Coulter Partners Covance Credos Consulting Limited Crescendo Biologics Ltd CROSSJECT (France) Current Partnering Cytox Ltd Data Magik Datamonitor Healthcare & SCRIP Intelligence Debiopharm International SA (Switzerland) Diligent Business Consulting Ltd DJS Antibodies Domainex Limited Dora Wirth Languages Drooms GmbH (Germany) EBD Group Enterprise Europe Network EY Eucodis Bioscience GmbH (Austria) Eurofins Bioanalytical Services Euromedica Europe Enterprise Network (EEN) EUSA Pharma Evotec (UK) Ltd F-star Biotechnology Ltd Fieldfisher FierceBiotech (USA) Financial Times Fisher Scientific FlandersBIO (Belgium) Fraunhofer Institute for Cell Therapy and Immunology (Germany) FreeMind Group (United States) Genomics England George James Ltd GlobalData Globe Life Sciences Hammersmith Medicines Research Harwell Oxford HC Pharma Consultancy Ltd Heptares Therapeutics Ltd HistologiX Horton International Hygieia Hypo-Stream Ltd i3a Technologies (Austria) Illingworth Research ImevaX GmbH (Germany) IMMT Ltd. (Slovenia) Informa (Citeline) Innovate UK Instinctif Partners Institut de Recherche Pierre Fabre (France) Inventages IP Asset IPI Irving Levin Associates Isansys Lifecare Isis Innovation JA Kemp James Cowper Kreston Jon Rees Associates JT Pharma (United States) Juno Therapeutics (USA) Kathryn Simpson Consulting Kevin Pritchard Consulting Key Organics King’s College London Life Science Nation Life Sciences Hub Wales Ludger Ltd LYONBIOPOLE (France) Management Learning & Coaching Manchester Science Partnerships Mapmyhealth

Mathys & Squire MedNous MEPC Ltd Mercia Technologies Mettler Toledo (Uganda) Milton Park MiNA Therapeutics Nanomerics Ltd Neovacs (France) Neurocentrx NIHR Biomedical Research Centre NIHR Clinical Research Network NIHR Moorfields Biomedical Research Centre NIMGenetics (Spain) Northern Powerhouse Nova Language Services Ltd. OBN (UK) Ltd OBS Medical Odgers Berndtson Office of Life Sciences OncoQR ML (Austria) Oryzon Genomics (Spain) Osborne Clarke Oxford Academic Health Science Network (AHSN) Oxford Cancer Biomarkers Oxford MESTAR Ltd Oxford Science Park Oxford University Oxford University Hospitals NHS Trust and the University of Oxford Parkinson’s UK Patheon (United States) Peakdale Molecular Pennington Manches LLP Peptinnovate Limited Perficient Pharm-Olam International Pharmalicensing Pharmaterials PharmaVentures Physiomics Plc PIQUR Therapeutics AG (Switzerland) Piramal Pharma Inc (Iceland) Piramal Pharma Solutions (India) Precision Medicine Catapult PRECLIN Biosystems AG (Switzerland) Proximagen Ltd Public Health England QRC Consultants Ltd Queen’s University Belfast Quintiles Quotient Clinical Re-Pharm Renfrew Group International Results Healthcare RRG, A VCLS Company RSA Ryboquin Company Ltd Safeguard Biosystems Samedan Ltd Sareum SCI Selcia Ltd Selvita Ltd SEP Sitatunga Ltd Somanautix Stratified Medicine Scotland STRI-bBHC (South Korea) Structural Genomics Consortium, University of Oxford Summit Therapeutics Sygnature Discovery Limited SynbiCITE Synpromics Ltd The BioHub Birmingham ® The Pharma Letter The Royal Veterinary College The Wellcome Trust (UK) Theradex Europe Tissue Regenix Tissue Solutions TRIANNI, Inc. (United States) Tusk Therapeutics UKTI Unguis Medical University of Leicester VirdisGroup Ltd. Virttu Biologics Ltd Warwick Ventures Ltd Wessex Academic Health Science Network Wessex Life Science Cluster WG Partners LLP Wickham Laboratories Limited Wiltshire Council World Courier WuXi AppTec Xplico A/S (Denmark) Zurich University of Applied Sciences (Switzerland)

PRESENTATION, SPONSORSHIP & EXHIBITION OPPORTUNITIES Maximise your presence and partnering opportunities at BioTrinity 2016 by securing a Company Showcase slot, becoming a BioTrinity Sponsor or exhibiting your company’s products. To find out more about the unique opportunities BioTrinity offers contact us today on +44 (0)845 5215 222 or email [email protected]

VISIT WWW.BIOTRINITY.COM TO BOOK YOUR TICKET TO PARTICIPATE

Thank you to the BioTrinity 2016 Sponsors: CORNERSTONE PATRONS

PLATINUM SPONSOR

INVESTOR SPONSORS

GOLD SPONSORS

SILVER SPONSORS

BRONZE SPONSORS

MEDIA SPONSOR

EVENT SUPPORTER

MEDIA SUPPORTERS